The NICE draft guideline states that: "Based on evidence of no major differences in clinical effectiveness between antibiotics or classes of antibiotics, the committee agreed that the choice of antibiotic should largely be driven by minimising the risk of resistance."
It also says the shortest course that is likely to be effective should be prescribed to reduce the risk of antimicrobial resistance.
In most cases this would be a 5 day course of all recommended antibiotics for acute exacerbation. However, a 7 day course may be appropriate in more severe cases.
The NICE consultation on the draft guideline runs until the 6th August 2018 and comments can be made via the NICE website.
© 2018 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Tim Locke. UK Guidelines Quiz: COPD & Antibiotics - Medscape - Jul 20, 2018.
Comments